NCT02805998

Brief Summary

The overarching goal is to utilize a randomized control design to examine efficacy of web-based cognitive behavior therapy (CBT-I) plus treatment as usual compared to treatment as usual alone for insomnia and depression outcomes among pregnant women with insomnia at high risk for depressive relapse/recurrence (n=208).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
208

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 20, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
5.2 years until next milestone

Results Posted

Study results publicly available

June 25, 2024

Completed
Last Updated

June 25, 2024

Status Verified

June 1, 2024

Enrollment Period

2.2 years

First QC Date

June 7, 2016

Results QC Date

April 27, 2022

Last Update Submit

June 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Insomnia Severity Index Scale Score

    Insomnia Severity Index (ISI). Scores on the ISI range from 0 to 28, with higher scores indicating more severe insomnia.

    Baseline to post-intervention (10 weeks post-randomization)

Secondary Outcomes (5)

  • Change in Percentage of Sleep Efficiency, as Determined by Daily Sleep Logs

    Baseline to post-intervention, an average of 8 weeks

  • Change in Sleep Duration, as Determined by Daily Sleep Logs

    Baseline to post-intervention, an average of 8 weeks

  • Change in Global Sleep Quality, as Determined by Pittsburgh Sleep Quality Index Score

    Baseline to post-intervention, an average of 8 weeks

  • Change in Depression Symptom Severity, as Determined by Edinburgh Postnatal Depression Scale Score

    Baseline to post-intervention, an average of 8 weeks

  • Change in Insomnia Diagnosis, as Determined by Sleep Condition Indicator

    Baseline to post-intervention, an average of 8 weeks

Study Arms (2)

Web-based CBT-I

EXPERIMENTAL

Sleepio delivers CBT-I through 6 weekly web-sessions. Treatment content is based on CBT for insomnia manuals and includes a behavioral component (sleep restriction, stimulus control, and relaxation), a cognitive component (paradoxical intention, cognitive restructuring, mindfulness, positive imagery, putting the day to rest) and an educational component (psycho-education, sleep hygiene).

Behavioral: Web-based CBT-IOther: Treatment as Usual

Treatment as Usual

OTHER

Our control condition was designed to reflect standard care for insomnia patients. No limits are placed on receiving non-study treatment, including medication or psychotherapy. Use of non-study treatment will be tracked.

Other: Treatment as Usual

Interventions

Web-based CBT-IBEHAVIORAL
Web-based CBT-I
Treatment as UsualWeb-based CBT-I

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pregnant up to 28 weeks gestation,
  • years of age or older,
  • Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for Insomnia disorder as determined by the Sleep Condition Indicator (SCI) or Insomnia Severity Index (ISI) score ≥ 11
  • regular access to a web-enabled computer, tablet, or smart phone.

You may not qualify if:

  • Probable major depression (Edinburgh Postnatal Depression Scale (EPDS) score ≥ 15),
  • self-reported bipolar disorder,
  • self-reported history of psychosis,
  • active suicidality defined as scoring \> 1 on EPDS item 10 or report of a specific suicide plan or recent attempt,
  • shift work employee,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF

San Francisco, California, 94118, United States

Location

Related Publications (2)

  • Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Randomized controlled trial of digital cognitive behavior therapy for prenatal insomnia symptoms: effects on postpartum insomnia and mental health. Sleep. 2022 Feb 14;45(2):zsab280. doi: 10.1093/sleep/zsab280.

  • Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women: A Randomized Clinical Trial. JAMA Psychiatry. 2020 May 1;77(5):484-492. doi: 10.1001/jamapsychiatry.2019.4491.

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Results Point of Contact

Title
Dr. Jennifer Felder
Organization
UCSF

Study Officials

  • Jennifer N Felder, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2016

First Posted

June 20, 2016

Study Start

October 1, 2016

Primary Completion

December 1, 2018

Study Completion

May 1, 2019

Last Updated

June 25, 2024

Results First Posted

June 25, 2024

Record last verified: 2024-06

Locations